PURINE ENZYME PROFILE IN HUMAN COLON-CARCINOMA CELL-LINES AND DIFFERENTIAL SENSITIVITY TO DEOXYCOFORMYCIN AND 2'-DEOXYADENOSINE IN COMBINATION

被引:21
作者
CAMICI, M
TURRIANI, M
TOZZI, MG
TURCHI, G
COS, J
ALEMANY, C
MIRALLES, A
NOE, V
CIUDAD, CJ
机构
[1] EUROPEAN CTR VALIDAT ALTERNAT METHODS,I-21027 ISPRA,ITALY
[2] UNIV BARCELONA,FAC FARM,UNITAT BIOQUIM,E-08028 BARCELONA,SPAIN
关键词
D O I
10.1002/ijc.2910620212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Different cell lines, 2 from human colon carcinoma (LoVo and HT29) and 1 from Chinese hamster ovary (CHO K-1), were examined to assess the effect of deoxycoformycin (dCF), an inhibitor of adenosine deaminase (ADA), and 2'-deoxyadenosine (dAdo) on their growth. When used alone, neither dCF or dAdo were cytotoxic for the 3 cell lines, while their combination caused inhibition of cell growth, with the following sensitivity: CHO K-1 > LoVo > HT29. We studied the pattern of enzymatic activities involved in the metabolism of dAdo in the 3 cell lines. The phosphorylation of dAdo by adenosine kinase appears to play a central role in the toxicity of the deoxynucleoside in combination with dCF. In fact, CHO K-1 cells, which are the most sensitive, possess the highest level of this enzyme. Moreover, the cytotoxic effect was almost completely reversed in the 3 cell lines when inhibitors of adenosine kinase, such as 5'-amino-5'-deoxyadenosine and iodotubercidine, were added to the culture medium together with dCF and dAdo. In addition, baby hamster kidney (BHK) adenosine-kinase-deficient (AK(-)) cells were highly resistant to this treatment. Uptake inhibition of dAdo using dipyridamole also caused reversal of the toxicity. The AMP and deoxy AMP dephosphorylating activities, much lower in the CHO K-1 cells, also appear to play a central role in the toxicity of dAdo when adenosine deaminase is inhibited. However, our data suggest that other factors may modulate the toxic effect, such as S-adenosyl-homocysteine-hydrolase inhibition by dAdo at high concentrations. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 25 条
[1]   TIGHT-BINDING INHIBITORS .4. INHIBITION OF ADENOSINE DEAMINASES BY VARIOUS INHIBITORS [J].
AGARWAL, RP ;
SPECTOR, T ;
PARKS, RE .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (05) :359-367
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
CALLARD RE, 1984, CLIN EXP IMMUNOL, V58, P136
[4]  
CAMICI M, 1990, CANCER BIOCHEM BIOPH, V11, P201
[5]  
CAMICI M, 1995, PURINE PYRIMIDINE ME, V8, P275
[6]   BIOCHEMICAL BASIS FOR THE ENHANCED TOXICITY OF DEOXYRIBONUCLEOSIDES TOWARD MALIGNANT HUMAN T-CELL LINES [J].
CARSON, DA ;
KAYE, J ;
MATSUMOTO, S ;
SEEGMILLER, JE ;
THOMPSON, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (05) :2430-2433
[7]   LYMPHO-SPECIFIC TOXICITY IN ADENOSINE-DEAMINASE DEFICIENCY AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY - POSSIBLE ROLE OF NUCLEOSIDE KINASE(S) [J].
CARSON, DA ;
KAYE, J ;
SEEGMILLER, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5677-5681
[8]  
DADDONA PE, 1981, J BIOL CHEM, V256, P2496
[9]   PENTOSTATIN IN PROLYMPHOCYTIC LEUKEMIA - PHASE-II TRIAL OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LEUKEMIA COOPERATIVE STUDY-GROUP [J].
DOHNER, H ;
HO, AD ;
THALER, J ;
STRYCKMANS, P ;
SONNEVELD, P ;
DEWITTE, T ;
LECHNER, K ;
LAURIA, F ;
BODEWADTRADZUN, S ;
SUCIU, S ;
SOLBU, G ;
WITT, B ;
HUNSTEIN, W ;
ZITTOUN, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) :658-662
[10]  
GIBLETT ER, 1972, LANCET, V2, P1067